Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jenna Bollyky"'
Autor:
Yingjie Weng, Di Lu, Jenna Bollyky, Vivek Jain, Manisha Desai, Christina Lindan, Derek Boothroyd, Timothy Judson, Sarah B. Doernberg, Marisa Holubar, Hannah Sample, Beatrice Huang, Yvonne Maldonado, George W. Rutherford, Kevin Grumbach, on behalf of the California Pandemic Consortium
Publikováno v:
Vaccines, Vol 9, Iss 12, p 1406 (2021)
Objective: The study was designed to compare intentions to receive COVID-19 vaccination by race–ethnicity, to identify beliefs that may mediate the association between race–ethnicity and intention to receive the vaccine and to identify the demogr
Externí odkaz:
https://doaj.org/article/0edb21f1fab84bb1ae3789176e9b4752
Autor:
Joseph E Levitt, Haley Hedlin, Sophie Duong, Di Lu, Justin Lee, Bryan Bunning, Nadia Elkarra, Benjamin A Pinsky, Eileen Heffernan, Eric Springman, Richard B Moss, Hector F Bonilla, Julie Parsonnet, Roham T Zamanian, Jamison J Langguth, Jenna Bollyky, Chaitan Khosla, Mark R Nicolls, Manisha Desai, Angela J Rogers
Publikováno v:
Clinical Infectious Diseases.
Background The vast majority of coronavirus disease 2019 (COVID-19) disease occurs in outpatients where treatment is limited to antivirals for high-risk subgroups. Acebilustat, a leukotriene B4 inhibitor, has potential to reduce inflammation and symp
Autor:
Timothy Judson, Shiqi Zhang, Christina P. Lindan, Derek Boothroyd, Kevin Grumbach, Jenna Bollyky, Hannah Sample, Beatrice Huang, Manisha Desai, Ralph Gonzales, Yvonne Maldonado, George W. Rutherford
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26c14f257f7f8133c8481208b5fc8912
https://doi.org/10.2139/ssrn.4352721
https://doi.org/10.2139/ssrn.4352721
Publikováno v:
Contemporary clinical trials. 120
Through a public County/University partnership, we employed a Spanish/English bilingual research coordinator to increase awareness of newly available treatments with FDA Emergency Use Authorization and clinical trial opportunities for Latino outpatie
Autor:
Kevin Grumbach, Yuteh Cheng, Ralph Gonzales, Alex Dahlen, George W. Rutherford, Jenna Bollyky, Sergio Garcia, Charles S. Craik, Timothy J. Judson, Derek B. Boothroyd, Manisha Desai, Hannah A. Sample, Haley Hedlin, Christina Lindan, Jeff Henne, Yingjie Weng, Yvonne Maldonado
Publikováno v:
Annals of Epidemiology
Purpose We describe the design of a longitudinal cohort study to determine SARS-CoV-2 incidence and prevalence among a population-based sample of adults living in six San Francisco Bay Area counties. Methods Using an address-based sample, we stratifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2f2ada0b53a4744b4570a70ed66d25
https://escholarship.org/uc/item/2v3351vw
https://escholarship.org/uc/item/2v3351vw
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 104:115763
The gold standard for COVID-19 diagnosis-reverse-transcriptase polymerase chain reaction (RT-PCR)- is expensive and often slow to yield results whereas lateral flow tests can lack sensitivity.We tested a rapid, lateral flow antigen (LFA) assay with a
Autor:
Vivek Jain, Yvonne Maldonado, Beatrice Huang, Jenna Bollyky, Sarah B Doernberg, Hannah A. Sample, Yingjie Weng, Manisha Desai, Marisa Holubar, Di Lu, George W. Rutherford
Publikováno v:
Open Forum Infectious Diseases
Autor:
Sarah B Doernberg, Jenna Bollyky, George W. Rutherford, Yingjie Weng, Di Lu, Timothy Judson, Christina Lindan, Vivek Jain, Beatrice Huang, Marisa Holubar, Kevin Grumbach, Yvonne Maldonado, Derek B. Boothroyd, Manisha Desai, Hannah Sample
Importance Surveys in the US have found that Black and Latinx individuals have more reservations than their white counterparts about COVID-19 vaccination. However, little is known about the degree to which racial-ethnic differences in COVID-19 vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa673fe27f67a8de5f01814283ffe39f
https://doi.org/10.1101/2021.04.26.21255893
https://doi.org/10.1101/2021.04.26.21255893
Autor:
Jacob Ghahremani, Yingjie Weng, Amanda Kempema, Aida Julien, Carina Marquez, George W. Rutherford, David V. Glidden, Di Lu, Hannah A. Sample, Guntas Padda, Yvonne Maldonado, Emerald Wan, Lillian Brown, Jessica Chao, Vivek Jain, Jenna Bollyky, Daisy Valdivieso, Kevin Grumbach, Sarah B Doernberg, Marcus Paoletti, Marisa Holubar, Sravya Jaladanki, Luis Rubio, Beatrice Huang, Christopher Leung, Matthew Sklar
BackgroundHealthcare personnel (HCP) are prioritized for earliest SARS-CoV-2 vaccine administration, yet relatively few data exist on HCP’s knowledge, motivations, concerns, and intentions regarding COVID-19 vaccines.MethodsWe conducted a cross-sec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8f8ab75e3a579c9b7886c132fba176c
https://doi.org/10.1101/2021.02.19.21251993
https://doi.org/10.1101/2021.02.19.21251993
Autor:
Mary Rieck, Srinath Sanda, Jenna Bollyky, S. A. Long, Mark Fitch, Paul L. Bollyky, Peter L. Samuels, Jane H. Buckner, Marc K. Hellerstein, R. Rogers, Carla J. Greenbaum
Publikováno v:
Clinical and Experimental Immunology. 172:363-374
Summary CD4+ memory cell development is dependent upon T cell receptor (TCR) signal strength, antigen dose and the cytokine milieu, all of which are altered in type 1 diabetes (T1D). We hypothesized that CD4+ T cell turnover would be greater in type